Predictors of the recurrence of surgically removed previous caesarean skin scars at caesarean section: A retrospective cohort study.
İhsan BağlıRei OgawaSait BakırCuma TaşınAyhan YıldırımEce ÖcalMustafa YavuzMesut BalaGökçe TuranPublished in: Scars, burns & healing (2021)
Background Caesarean skin scars (CSS; hypertrophic scars and keloids) are very stressful and are generally itchy and painful for women. Treatment strategies vary. However, there is a lack of knowledge about the outcome of only surgical excision of CSS scars during caesarean section (CS). The issue being explored There are few data in the literature for CSS in the lower abdomen. These scars can be removed during the second or third CS, but the results are not known exactly. How was the work conducted? In our clinic, 145 patients with CSS were given a CS and their scars were removed at the same time. While most of these scars were reported as hypertrophic by pathological examination, some were reported as keloid. At the earliest, one year after surgery, the rate of recurrence was found to be 13%. What we learned from the study Asymptomatic patients who are planning another pregnancy and do not want to receive any other radiotherapy or steroid injection therapy can wait to remove their CSS at the next CS, especially elective CS with or without adjunct therapy. Emergency CS was found to be a risk factor for the recurrence of these scars.
Keyphrases
- platelet rich plasma
- healthcare
- emergency department
- public health
- systematic review
- newly diagnosed
- squamous cell carcinoma
- early stage
- end stage renal disease
- electronic health record
- pregnancy outcomes
- adipose tissue
- free survival
- type diabetes
- big data
- insulin resistance
- bone marrow
- ultrasound guided
- smoking cessation
- rectal cancer